ResearchWorks Archive
    • Login
    View Item 
    •   ResearchWorks Home
    • Faculty and Researcher Data and Papers
    • Genome Sciences, Department of
    • Department of Genome Sciences Faculty Papers
    • View Item
    •   ResearchWorks Home
    • Faculty and Researcher Data and Papers
    • Genome Sciences, Department of
    • Department of Genome Sciences Faculty Papers
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    World Antimalarial Resistance Network (WARN) III: Molecular markers for drug resistant malaria

    Thumbnail
    View/Open
    1475-2875-6-121.pdf (536.2Kb)
    Date
    2007
    Author
    Plowe, Christopher V.
    Roper, Cally
    Barnwell, John W.
    Happi, Christian T.
    Joshi, Hema H.
    Mbacham, Wilfred
    Meshnick, Steven R.
    Mugittu, Kefas
    Naidoo, Inbarani
    Price, Ric N.
    Shafer, Robert W.
    Sibley, Carol Hopkins
    Sutherland, Colin J.
    Zimmerman, Peter A.
    Rosenthal, Phillip J.
    Metadata
    Show full item record
    Abstract
    Molecular markers for drug resistant malaria represent public health tools of great but mostly unrealized potential value. A key reason for the failure of molecular resistance markers to live up to their potential is that data on the their prevalence is scattered in disparate databases with no linkage to the clinical, in vitro and pharmacokinetic data that are needed to relate the genetic data to relevant phenotypes. The ongoing replacement of older monotherapies for malaria by new, more effective combination therapies presents an opportunity to create an open access database that brings together standardized data on molecular markers of drug resistant malaria from around the world. This paper presents a rationale for creating a global database of molecular markers for drug resistant malaria and for linking it to similar databases containing results from clinical trials of drug efficacy, in vitro studies of drug susceptibility, and pharmacokinetic studies of antimalarial drugs, in a World Antimalarial Resistance Network (WARN). This database will be a global resource, guiding the selection of first line drugs for treating uncomplicated malaria, for preventing malaria in travelers and for intermittent preventive treatment of malaria in pregnant women, infants and other vulnerable groups. Perhaps most important, a global database for molecular markers of drug resistant malaria will accelerate the identification and validation of markers for resistance to artemisinin-based combination therapies and, thereby, potentially prolong the useful therapeutic lives of these important new drugs.
    URI
    http://www.malariajournal.com/content/6/1/121
    http://hdl.handle.net/1773/15844
    Collections
    • Department of Genome Sciences Faculty Papers [15]

    DSpace software copyright © 2002-2015  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    @mire NV
     

     

    Browse

    All of ResearchWorksCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    DSpace software copyright © 2002-2015  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    @mire NV